Hua G Lin

US Patent:

7069291, Jun 27, 2006

Filed:

Jun 14, 2002

Appl. No.:

10/172782

Inventors:

Richard C. Graves - Nashville TN, US
Song Liu - Richardson TX, US
Hua Lin - Windham NH, US

Assignee:

CopperCom, Inc. - Boca Raton FL

International Classification:

G06F 15/16

US Classification:

709201, 709202, 709217

Abstract:

Improved systems and methods for call and call feature setup, administration and processing on PSTN and other telecommunications networks are provided. Calls are set up on a service plane of a conceptual switch that includes a switch plane, control plane, and service plane that are analogous to the OSI layered model of networks including a physical layer, network layer and application layer. Call set-up logic is separated from the switching fabric, allowing for flexible, on-demand, modification of service options using software while maintaining the same switching fabric in hardware. Call set-up is accomplished by a call request made upon connection of a call to the switch. This causes a call agent to search an eXtensible Markup Language knowledge base to find a web page corresponding to the initiating caller. The Web page may be collocated with the switch or on a LAN with the switch or on the “Web,” even on the caller's termination equipment (telephone).

US Patent:

20220185797, Jun 16, 2022

Filed:

Mar 25, 2020

Appl. No.:

17/598695

Inventors:

- New York NY, US
- Weston MA, US
Donald W. LANDRY - New York NY, US
Robert J. DEVITA - Westfield NJ, US
Hua V. LIN - Zionsville IN, US
Yunkyoung LEE - New York NY, US
Domenico ACCILI - New York NY, US
Sandro BELVEDERE - Weston MA, US

International Classification:

C07D 403/04
A61K 31/713
A61K 31/4184
A61K 31/496
C07D 401/14
A61K 31/454
C07D 405/14
C07D 413/14
A61K 31/423
A61K 31/4709
A61K 31/4439
C07D 471/04
A61K 31/437

Abstract:

Various embodiments relate to a compound (represented by Formula I) or a pharmaceutically acceptable salt or tautomer thereof. The compound may selectively inhibit a Forkhead Box O1 (FOXO1) transcription factor. Various embodiments relate to methods comprising administering to a mammal having a disease or disorder associated with impaired pancreatic endocrine function, a therapeutically effective amount of the compound or a pharmaceutically acceptable salt or tautomer thereof. Various embodiments relate to methods for producing enteroendocrine cells that make and secrete insulin in a mammal, comprising administering to the mammal an effective amount of the compound or a pharmaceutically acceptable salt or tautomer thereof.